Madison-based drug discovery and development company Metagen Corp. closed a $535,000 seed investment round with the Marquette University Golden Angels Network, the investment group reported Wednesday....
Gov. Jim Doyle on Monday expressed hope for the future of stem cell research, lauding Senate Majority Leader Bill Frist's recent decision to support removal of some of the current limitations on such research....
Delivering a bag of used syringes to a public office building isn't the way to influence skeptics, and it undermines the need for a civil debate. Still, many people who could someday benefit from stem cell research are asking: Why is science being held back...
Wisconsin Alumni Research Foundation has licensed the California immunological research firm Chemicon to commercialize research products using WARF's stem cell patents....
Madison, Wis. - The Center for Technology Transfer has committed $350,000 in funding to Erie, Pa.-based Spinworks LLC, a company that has developed a series of technologies that will enable Wisconsin thermal metal processing companies to reduce usage of natural gas in their...
Madison's High Tech Happy Hour will mark its fourth anniversary with a gathering this Wednesday, July 27, and announces that a new alliance will coordinate the events....
CHICAGO – As witnessed by the BIO 2005 meeting in Philadelphia last month, the globalization of the biotech industry beyond its U.S. roots has really taken flight. ...
After months of debate and restructuring Gov. Jim Doyle has signed the Wisconsin state budget for 2005-2007 - at the expense of the Biomedical Technology Alliance. ...
New Richmond, Wis. - Wisconsin Gov. Jim Doyle said he would sign into the state budget up to $5 million for agricultural and forestry bio-industry development. The funds are part of a major new bio-based initiative announced in June....
Madison, Wis. - The natural world has been medicine's most effective arsenal, providing life-saving antibiotics and our most potent anti- cancer drugs. Now, with help from the National Cancer Institute (NCI), a consortium of University of Wisconsin-Madison scientists will embark on a five-year program of drug...